By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Mary Jane's PostMary Jane's Post
  • Tech
  • Science
  • Culture & Arts
  • Press Releases
  • More
    • About Us
    • Advertise
    • Monthly Give-Away
    • Partner With Us
  • Join UsNew
Reading: Heritage Cannabis Announces Supply Agreements and First Shipment of Opticann Medical Products to Australia
Share
0

No products in the cart.

Aa
Mary Jane's PostMary Jane's Post
Aa
  • Press Releases
  • Submit News
  • Join UsNew
Search
  • Topics
    • Business
    • Cannabis Community
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Press Releases
  • About Us
    • Guest Columnist
    • Ambassador
    • Partner With Us
Have an existing account? Sign In
Follow US
©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.
Mary Jane's Post > Press Releases > Heritage Cannabis Announces Supply Agreements and First Shipment of Opticann Medical Products to Australia
Press Releases

Heritage Cannabis Announces Supply Agreements and First Shipment of Opticann Medical Products to Australia

Business Wire
Posted Business Wire October 4, 2021
Updated 2021/10/04 at 11:47 AM
3 Min Read
SHARE

Opticann completes shipments of CBD filmstrips formulated with Heritage CBD and manufactured using IntelGenx VersaFilm® technology

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce its subsidiary Opticann has signed two supply agreements with two well established Australian companies for the supply of medical cannabis products. The first shipment of medical cannabis CBD/CBDA filmstrips totalling $60,000 was recently completed.

Logo Cannabis News

As previously announced, Heritage has a limited exclusive agreement with IntelGenx Corp. (”IntelGenx”) (TSX V:IGX) (OTCQB:IGXT) for CBD filmstrip products based on IntelGenx’s VersaFilm® technology for the Canadian and Australian markets. Pursuant to the Agreement, Heritage supplies CBD raw material for IntelGenx’s filmstrip manufacture and supply in Canada and Australia for Heritage to distribute.

Umar Syed, Heritage’s President of the Medical Division, commented: “Australia is an important and quickly growing medical market, as it is poised to grow at over 30% CAGR between now and 2028 according to Grand View Research. Our Australian distribution partners were carefully selected for their ability to develop the market for CBD products, and to monitor for evolving TGA regulations, including possible S3 classification that enables over-the-counter CBD product distribution. Our proprietary rapidly dissolving sublingual CBD Filmstrips are unique (CB4 Control filmstrips in Canada) in providing medical patients with rapid onset and maximum bioavailability of CBD versus oral products. We are excited to have completed our first shipments to Australia and look to add additional products in the future.”

“As we continue to grow our market and brand distribution in Canada, it is important for us to monitor and act on new markets with a strategic approach in order to capitalize on new market opportunities,” stated David Schwede, CEO of Heritage. “By partnering with these well established companies in Australia, we can leverage their local knowledge and expertise, while minimizing the costs and risks of entering new markets.”

The CBD Filmstrips are produced at IntelGenx’s manufacturing facility under Canadian GPP conditions and will be registered as a product for sale with the Australian Department of Health’s Therapeutic Goods Administration as medicinal cannabis.

About Opticann

Opticann’s suite of CB4 medical cannabis products are based on trusted pharmaceutical technology platforms that are optimized for the effective delivery of cannabinoids – for maximum effect and to minimize unwanted effects.

Opticann proprietary and patent protected products are based on innovative pharmaceutical technology that deliver the best results consistently, safely, and in convenient dosage forms (capsules, sublingual filmstrips, and topicals). These dosage forms are tested and optimized to deliver active ingredients for effective results. Opticann products also contain the highest quality ingredients and are thoroughly quality tested for consistency.

About Heritage

Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood, CB4 suite of medical products in Canada and ArthroCBD in the US.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“David Schwede”

David Schwede

CEO

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Cannabis News

Contacts

Kelly Castledine

Tel: 647-660-2560

[email protected]

You Might Also Like

Heritage Cannabis Reports 2021 Year-End Financial Results

Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

Houston Area Army Veteran Reclaims Life, Eliminates Opioid Use with Medical Cannabis

Heritage Cannabis Announces Corporate Update and Highlights Significant Sales Growth, Market Share and Growing Distribution

TAGGED: Business Wire
Business Wire October 4, 2021
Share this Article
Facebook Twitter Pinterest LinkedIn Reddit
Share
Business Wire
Posted by Business Wire
Follow:
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.
Previous Article United States State-by-State CBD Vaping Products Regulation Report 2021 – ResearchAndMarkets.com
Next Article Liberated Syndication Announces Appointment of New Chief Financial Officer
- Advertisement -
Ad imageAd image

Stay Connected

Facebook Like
Twitter Follow
Pinterest Pin
Instagram Follow

You Might Also Like

Heritage Cannabis Reports 2021 Year-End Financial Results

May 12, 2022

Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca

May 11, 2022

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

May 11, 2022

Houston Area Army Veteran Reclaims Life, Eliminates Opioid Use with Medical Cannabis

May 11, 2022
Mary Jane's PostMary Jane's Post

©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.

  • PRIVACY
  • TERMS OF USE
  • CONTRIBUTOR AGREEMENT
  • CONTRIBUTOR GUIDELINES

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Register Lost your password?